Summary
It has been questioned whether aiming at near-normoglycaemia by intensified insulin treatment regimens is feasible and safe for the majority of patients with insulin-dependent diabetes. In this study, intensified insulin injection therapy (including blood glucose self-monitoring and multiple insulin injections) based upon a 5-day inpatient group teaching programme was evaluated in Type 1 (insulin-dependent) diabetes mellitus in the centralised health care system of Bucharest. One hundred patients (group A, initial HbA1 12.5%) were followed for 1 year on their standard therapy (individual teaching, no metabolic self-monitoring), and thereafter for 1 year on intensified therapy. Another 100 patients (group B, HbA1 12.3%) were followed for 2 years on intensified therapy. A third 100 patients (group C, HbA1 11.7%) were assigned to a basic 4-day inpatient group teaching programme with conventional insulin therapy (including self-monitoring of glucosuria and acetonuria) and followed for 1 year. Mean HbA1 remained unchanged after standard treatment (group A: 12.8% at 12 months), but decreased during intensified therapy (group A: 10.1% at 24 months; group B: 9.3% at 12 months, 9.5% at 24 months; p<0.0001). In group C, no change was found compared to standard treatment (i.e. group A at 12 months). Incidence rates of ketoacidosis were 0.16 episodes per patient per year during standard treatment, 0.01 during intensified treatment (p<0.01) and 0.04 in group C (p<0.025). Hospitalisation rates were reduced by 60% during intensified therapy and by 40% in group C. Frequency of severe hypoglycaemia was not significantly different between the three treatment regimens. Thus, under the condition that insulin treatment is based upon a structured and comprehensive training of the patient, intensified insulin injection therapy performed as routine treatment of Type 1 diabetes significantly lowers HbA1 levels without increasing the risk of severe hypoglycaemia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596
Jovanovic L, Peterson CM, Saxena BB, Dawood MY, Saudek CD (1980) Feasibility of maintaining normal glucose profiles in insulin-dependent pregnant diabetic women. Am J Med 68: 105–112
Schiffrin A, Belmonte MM (1982) Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. A one-year prospective study. Diabetes 31: 255–264
Reeves ML, Seigier DE, Ryan EA, Skyler JS (1982) Glycemie control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. Am J Med 72: 673–680
Unger RH (1982) Meticulous control of diabetes: benefits, risks, and precautions. Diabetes 31: 479–483
The DCCT Research Group (1986) The diabetes control and complications trial (DCCT). Design and methodologic considerations for the feasibility phase. Diabetes 35: 530–545
Mühlhauser I, Jörgens V, Berger M, Graninger W, Gürtler W, Hornke L, Kunz A, Schernthaner G, Scholz V, Voss HE (1983) Bicentric evaluation of a teaching and treatment programme for Type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 25: 470–476
Mühlhauser I, Berger M, Sonnenberg GE, Koch J, Jörgens V, Schernthaner G, Scholz V (1985) Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care 8: 268–273
Assal JP, Mühlhauser I, Pernet A, Gfeller R, Jörgens V, Berger M (1985) Patient education as the basis for diabetes care in clinical practice and research. Diabetologia 28: 602–613
Kramer MS, Shapiro SH (1984) Scientific challenges in the application of randomized trials. JAMA 252: 2739–2745
Chantelau EA, Sonnenberg GE, Stanitzek-Schmidt I, Best F, Altenähr H, Berger M (1982) Diet liberalization and metabolic control in type-1 diabetic outpatients treated by continuous subcutaneous insulin infusion. Diabetes Care 5: 612–616
Chantelau EA, Frenzen A, Gösseringer G, Hansen I, Berger M (1987) Intensive insulin therapy justifies simplification of the diabetes diet: a prospective study in insulin-dependent diabetics. Am J Clin Nutr 45: 958–962
Chantelau EA, Gösseringer G, Sonnenberg GE, Berger M (1985) Moderate intake of sucrose does not impair metabolic control in pump-treated diabetic out-patients. Diabetologia 28: 204–207
Mühlhauser I, Koch J, Berger M (1985) Pharmacokinetics and bioavailability of injected glucagon: differences between intramuscular, subcutaneous and intravenous administration. Diabetes Care 8: 39–42
Seidel A (1987) Comparison of methods of urine glucose measurement. M. D. Thesis, University of Düsseldorf, FRG
Ionescu-Tîrgovişte C, Mincu I, Simionescu L, Cheţa D, Mirodon Z, Sântu E, Popa E, Bîrnea A (1984) Disappearance rate of insulin antibodies after discontinuing insulin treatment in 42 Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 27: 592–595
Siegel S (1976) Nichtparametrische statistische Methoden. Fachbuchhandlung für Psychologie, Frankfurt
Mecklenburg RS, Benson EA, Benson JW, Fredlund PN, Guinn T, Metz RJ, Nielsen RL, Sannar CA (1984) Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA 252: 3265–3269
Klein R, Klein BEK, Davis MD (1983) Is cigarette smoking associated with diabetic retinopathy? Am J Epidemiol 118: 228–238
Peacock I, Tattersall RB, Taylor A, Douglas CA, Reeves WG (1983) Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control. Lancet 1: 149–152
The Kroc Collaborative Study Group (1984) Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial. N Engl J Med 311: 365–372
Bending JJ, Pickup JC, Keen H (1985) Frequency of diabetic ketoacidosis and hypoglycemie coma during treatment with continuous subcutaneous insulin infusion. Am J Med 79: 685–691
Feldt-Rasmussen B, Mathiesen ER, Deckert T (1986) Effect of two years of strict metabolic control of progression on incipient nephropathy in insulin-dependent diabetes. Lancet 2: 1300–1304
Dahl-Jørgensen KD, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Aagenaes Ø (1986) Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy: the Oslo study. Br Med J 293: 1195–1199
Hanssen KF, Dahl-Jørgensen K, Lauritzen T, Feldt-Rasmussen B, Brinchmann-Hansen O, Deckert T (1986) Diabetic control and microvascular complications: the near-normoglycaemic experience. Diabetologia 29: 677–684
Worth R, Home PD, Johnston DG, Anderson J, Ashworth L, Burrin JM, Appleton D, Binder C, Alberti KGMM (1982) Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. Br Med J 285: 1233–1240
The DCCT Research Group (1987) Diabetes control and complications trial (DCCT): results of feasibility study. Diabetes Care 10: 1–19
Basdevant A, Costagliola D, Lanöe JL, Goldgewicht C, Triomphe A, Metz F, Denys H, Eschwege E, Fardeau M, Tchobroutsky G (1982) The risk of diabetic control: a comparison of hospital versus general practice supervision. Diabetologia 22: 309–314
Potter J, Clarke P, Gale EAM, Dave SH, Tattersall RB (1982) Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg? Br Med J 285: 1180–1182
Miller LV, Goldstein J (1972) More efficient care of diabetic patients in a county-hospital setting. N Engl J Med 286: 1388–1391
Mühlhauser I, Klemm AB, Boor B, Scholz V, Berger M (1986) Krankenhausaufenthalts- und Arbeitsunfähigkeitszeiten bei Patienten mit Typ-I-Diabetes. Einfluß eines Diabetes-Behandlungsund Schulungsprogramms. Dtsch Med Wochenschr 111: 854–857
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mühlhauser, I., Bruckner, I., Berger, M. et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of Type 1 (insulin-dependent) diabetes. Diabetologia 30, 681–690 (1987). https://doi.org/10.1007/BF00296989
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00296989